Artificial Intelligence, a tool for accelerated advances in oncology

The world’s leading experts in the study of the RAS oncogene have gathered in Salamanca to participate in the “Symposium Targeting RAS. New challenges and avenues”. The prestigious researcher Mariano Barbacid, head of the Experimental Oncology Group at the Spanish National Cancer Research Centre (CNIO), one of the world’s leading biomedical research centers, and Eugenio Santos, director of the Salamanca Cancer Centre, were also present. In addition, among the attendees were promising young people, such as Alberto J. Schumacher, ARAID researcher, head of the Molecular Oncology group at the Aragon Institute for Health Research, and a great believer in the role of Artificial Intelligence and technology in future advances, also in the field of oncology.

Alberto J. Schuhmacher at the symposium on the RAS oncogene held in Salamanca.

Years ago, it seemed impossible to have drugs to treat mutations in the RAS oncogene, but the congress held in Salamanca over the past few days has been aimed at sharing the important achievements that are being made in this field. In all of them, the development of new technologies capable of analyzing millions of data has been fundamental, and in the coming years we will experience a revolution in the diagnosis and treatment of oncological diseases thanks to AI.

Alberto J. Schuhmacher at the symposium on the RAS oncogene held in Salamanca.

The BISITE Research Group of the University of Salamanca and the Air Institute are involved in numerous bio-health projects. These include the computational design of vaccines; adaptive neuromodulation and prediction based on Artificial Intelligence, both projects with important applications in epilepsy; advanced analysis of biomedical signals; a tool for the automatic classification of medical images that is already being used at the University Hospital of Salamanca; the generation of artificial data to train artificial neural networks; a large platform for the analysis of genomic data and the development of analysis of large hospital databases to improve management.

Alberto J. Schuhmacher at the symposium on the RAS oncogene held in Salamanca.

Some of these projects are still in their infancy, others are well underway, but all are examples of how AI will transform healthcare as we know it today. These types of initiatives can be developed thanks to research and education, such as the Master’s Degree in Digital Transformation and the Master’s Degree in Smart Cities, coordinated by the BISITE Research Group.

Juan Manuel Corchado

Full Professor in Computer Science and Artificial Intelligence, Department of Computer Science and Automation, University of Salamanca, Spain.


Contents: – e4YOU – Másteres – CyberCamp

Scientific: ORCIDScholarResearch GateWeb of Science

Join 2,320 other subscribers